Canton, OHIO4 Active Studies

Myelofibrosis Clinical Trials in Canton, OHIO

Find 4 actively recruiting myelofibrosis clinical trials in Canton, OHIO. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
393
Enrolling

Recruiting Myelofibrosis Studies in Canton

RecruitingCanton, OHIONCT05320198

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

This phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofi...

150 participants
Disc Medicine, Inc
View Study Details
RecruitingCanton, OHIONCT04655118

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

This study evaluates TL-895, a potent, orally-available and highly selective irreversible tyrosine kinase inhibitor for the treatment of Myelofibrosis (Cohorts 1-3) or Indolent Systemic Mastocytosis (...

121 participants
Telios Pharma, Inc.
View Study Details
RecruitingCanton, OHIONCT05280509

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

This study evaluates TL-895, a potent, orally-available and highly selective irreversible tyrosine kinase inhibitor for the treatment of Myelofibrosis. Participants must have MF (PMF, Post PV MF, or P...

70 participants
Telios Pharma, Inc.
View Study Details
RecruitingCanton, OHIONCT04878003

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

This study evaluates either KRT-232 or TL-895 in treatment naïve patients with myelofibrosis (MF) The study will be conducted in 2 stages. Stage 1 will evaluate safety, tolerability, and efficacy of ...

52 participants
Kartos Therapeutics, Inc.
View Study Details

About Myelofibrosis Clinical Trials in Canton

Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.

There are currently 4 myelofibrosis clinical trials recruiting participants in Canton, OHIO. These studies are seeking a combined 393 participants. Research is being sponsored by Disc Medicine, Inc, Telios Pharma, Inc., Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myelofibrosis Clinical Trials in Canton — FAQ

Are there myelofibrosis clinical trials in Canton?

Yes, there are 4 myelofibrosis clinical trials currently recruiting in Canton, OHIO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Canton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Canton research site will contact you about next steps.

Are clinical trials in Canton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Canton studies also compensate for your time and travel.

What myelofibrosis treatments are being tested?

The 4 active trials in Canton are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.

Data updated March 2, 2026 from ClinicalTrials.gov